Review paper
Innovative Radiopharmaceuticals for Cancer Diagnosis and Treatment
Volume: 3, Issue: 4, Pages: 26 - 38
Published: Dec 31, 2020
Abstract
The presented material summarizes the experience of Cancer Research Institute and Tomsk Polytechnical University team in the development of original radiopharmaceuticals (RP) for nuclear medicine. The first such unique for world nuclear medicine RP was a Thallium199. The Thallium199 is successfully used for breast cancer diagnosis and its lymphogenous metastasis, as well as to visualize cancer of the larynx and laryngopharynx, their relapses...
Paper Details
Title
Innovative Radiopharmaceuticals for Cancer Diagnosis and Treatment
Published Date
Dec 31, 2020
Volume
3
Issue
4
Pages
26 - 38
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History